Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multifaced Approach of Assessing Upper Extremity Proprioception in Breast Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy

NCT07367711 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT07367711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07367711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multifaced Approach of Assessing Upper Extremity Proprioception in Breast Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
November 30, 2027
Enrollment
145 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, chemotherapy-induced peripheral neuropathy in breast cancer, cipn - chemotherapy-induced peripheral neuropathy